{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:36:41Z","timestamp":1792132601584,"version":"4.4.0"},"reference-count":190,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T00:00:00Z","timestamp":1686787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Cirrhosis transcends various progressive stages from compensation to decompensation driven by the severity of portal hypertension. The downstream effect of increasing portal hypertension severity leads to various pathophysiological pathways, which result in the cardinal complications of cirrhosis, including ascites, variceal hemorrhage, and hepatic encephalopathy. Additionally, the severity of portal hypertension is the central driver for further advanced complications of hyperdynamic circulation, hepatorenal syndrome, and cirrhotic cardiomyopathy. The management of these individual complications has specific nuances which have undergone significant developments. In contrast to the classical natural history of cirrhosis and its complications which follows an insidious trajectory, acute-on-chronic failure (ACLF) leads to a rapidly downhill course with high short-term mortality unless intervened at the early stages. The management of ACLF involves specific interventions, which have quickly evolved in recent years. In this review, we focus on complications of portal hypertension and delve into an approach toward ACLF.<\/jats:p>","DOI":"10.3389\/fmed.2023.1060073","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T05:49:04Z","timestamp":1686808144000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":46,"title":["Pathophysiology and management of liver cirrhosis: from portal hypertension to acute-on-chronic liver failure"],"prefix":"10.3389","volume":"10","author":[{"given":"Rakesh Kumar","family":"Jagdish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karan","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhumita","family":"Premkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithun","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padaki Nagaraja","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duvvur Nageshwar","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand V.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","volume":"5","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"J Hepatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.jceh.2022.03.002","article-title":"Management of portal hypertension","volume":"12","author":"Kulkarni","year":"2022","journal-title":"J Clin Exp Hepatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/cld.1209","article-title":"The challenges of ascites management: An Indian perspective","volume":"19","author":"Kulkarni","year":"2022","journal-title":"Clin Liver Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/MCC.0b013e328344a076","article-title":"Acute-on-chronic liver failure: the liver and portal haemodynamics","volume":"17","author":"Mookerjee","year":"2011","journal-title":"Curr Opin Crit Care."},{"key":"B6","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.cld.2019.07.007","article-title":"Portal hypertension: pathogenesis and diagnosis","volume":"23","author":"Turco","year":"2019","journal-title":"Clin Liver Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1055\/s-0037-1617455","article-title":"Liver sinusoidal endothelial cell: an update","volume":"37","author":"DeLeve","year":"2017","journal-title":"Semin Liver Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.jhep.2017.12.027","article-title":"Cardiopulmonary hemodynamics and C-reactive protein as prognostic indicators in compensated and decompensated cirrhosis","volume":"68","author":"Turco","year":"2018","journal-title":"J Hepatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","article-title":"Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis","volume":"133","author":"Ripoll","year":"2007","journal-title":"Gastroenterology."},{"key":"B10","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/hep.20061","article-title":"Targeting portal pressure measurements: a critical reappraisal","volume":"39","author":"Thalheimer","year":"2004","journal-title":"Hepatology."},{"key":"B11","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S0016-5085(99)70455-5","article-title":"Prognostic value of early measurements of portal pressure in acute variceal bleeding","volume":"117","author":"Moitinho","year":"1999","journal-title":"Gastroenterology."},{"key":"B12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1053\/gast.2001.25536","article-title":"Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding","volume":"121","author":"Villanueva","year":"2001","journal-title":"Gastroenterology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1002\/hep.20386","article-title":"Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding","volume":"40","author":"Monescillo","year":"2004","journal-title":"Hepatology."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1111\/liv.14936","article-title":"Fresh frozen plasma transfusion in acute variceal haemorrhage: results from a multicentre cohort study","volume":"41","author":"Mohanty","year":"2021","journal-title":"Liver Int."},{"key":"B15","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology."},{"key":"B16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1211801","article-title":"Transfusion strategies for acute upper gastrointestinal bleeding","volume":"368","author":"Villanueva","year":"2013","journal-title":"N Engl J Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1053\/j.gastro.2019.03.070","article-title":"AGA clinical practice update: coagulation in cirrhosis","volume":"157","author":"O'Leary","year":"2019","journal-title":"Gastroenterology."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1055\/s-0038-1666861","article-title":"Concepts and controversies in haemostasis and thrombosis associated with liver disease: proceedings of the 7th international coagulation in liver disease conference","volume":"118","author":"Intagliata","year":"2018","journal-title":"Thromb Haemost."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1002\/hep.22216","article-title":"Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: a randomized, controlled trial","volume":"47","author":"Bosch","year":"2008","journal-title":"Hepatology."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1002\/hep.510270504","article-title":"Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage","volume":"27","author":"Goulis","year":"1998","journal-title":"Hepatology."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.cgh.2014.11.019","article-title":"Risk of bacterial infection in patients with cirrhosis and acute variceal hemorrhage, based on child-pugh class, and effects of antibiotics","volume":"13","author":"Tandon","year":"2015","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/hep.27006","article-title":"Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage","volume":"60","author":"Seo","year":"2014","journal-title":"Hepatology."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1136\/gutjnl-2020-323054","article-title":"Timing of endoscopy for acute upper gastrointestinal bleeding: a territory-wide cohort study","volume":"71","author":"Guo","year":"2022","journal-title":"Gut."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1111\/j.1572-0241.2006.00582.x","article-title":"Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial","volume":"101","author":"Carbonell","year":"2006","journal-title":"Am J Gastroenterol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S2468-1253(19)30090-1","article-title":"Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial","volume":"4","author":"Lv","year":"2019","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/hep.30182","article-title":"Preemptive-TIPS improves outcome in high-risk variceal bleeding: an observational study","volume":"69","author":"Hern\u00e1ndez-Gea","year":"2019","journal-title":"Hepatology."},{"key":"B27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/poh2.35","article-title":"Antibiotic prophylaxis in cirrhosis patients with upper gastrointestinal bleeding: an updated systematic review and meta-analysis","volume":"1","author":"Wong","year":"2022","journal-title":"Portal Hypertens Cirrhosis."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2023.01.013","article-title":"Identification of risk factors associated with bacterial infections in Child-A cirrhosis with variceal bleeding","author":"Sharma","year":"2023","journal-title":"J Clin Exp Hepatol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1007\/s10620-022-07744-w","article-title":"MELD-lactate predicts poor outcome in variceal bleeding in cirrhosis","volume":"68","author":"Horvatits","year":"2022","journal-title":"Dig Dis Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1053\/j.gastro.2013.10.018","article-title":"A MELD-based model to determine risk of mortality among patients with acute variceal bleeding","volume":"146","author":"Reverter","year":"2014","journal-title":"Gastroenterology."},{"key":"B31","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - renewing consensus in portal hypertension: report of the Baveno VII Consensus Workshop: personalized care in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/poh2.18","article-title":"Nonselective beta-blockers reduce mortality in patients with acute-on-chronic liver failure","volume":"1","author":"Kulkarni","year":"2022","journal-title":"Portal Hypertens Cirrhosis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s12072-019-09986-9","article-title":"Treatment with carvedilol improves survival of patients with acute-on-chronic liver failure: a randomized controlled trial","volume":"13","author":"Kumar","year":"2019","journal-title":"Hepatol Int."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/S0140-6736(18)31875-0","volume":"393","author":"Villanueva","year":"2019","journal-title":"Lancet"},{"key":"B35","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1067\/mge.2001.114062","article-title":"The effects of endoscopic variceal ligation and propranolol on portal hypertensive gastropathy: a prospective, controlled trial","volume":"53","author":"Lo","year":"2001","journal-title":"Gastrointest Endosc."},{"key":"B36","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/MCG.0000000000001219","article-title":"Carvedilol combined with ivabradine improves left ventricular diastolic dysfunction, clinical progression, and survival in cirrhosis","volume":"54","author":"Premkumar","year":"2020","journal-title":"J Clin Gastroenterol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s12072-021-10227-1","article-title":"Primary prophylaxis of gastric variceal bleeding: the choices need to be tested!! Hepatol Int","volume":"15","author":"Vashishtha","year":"2021"},{"key":"B38","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1007\/s12072-021-10154-1","article-title":"Primary prophylaxis of gastric variceal bleeding: endoscopic obturation, radiologic intervention, or observation?","volume":"15","author":"Choe","year":"2021","journal-title":"Hepatol Int."},{"key":"B39","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0140-6736(80)90063-X","article-title":"Propranolol\u2013a medical treatment for portal hypertension?","volume":"2","author":"Lebrec","year":"1980","journal-title":"Lancet."},{"key":"B40","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s12072-016-9765-y","article-title":"Carvedilol versus propranolol effect on hepatic venous pressure gradient at 1 month in patients with index variceal bleed: RCT","volume":"11","author":"Gupta","year":"2017","journal-title":"Hepatol Int."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1136\/gutjnl-2013-306502","article-title":"Non-selective \u03b2-blockers are associated with improved survival in patients with ascites listed for liver transplantation","volume":"64","author":"Leithead","year":"2015","journal-title":"Gut."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1111\/jgh.13303","article-title":"Early TIPS versus endoscopic therapy for secondary prophylaxis after management of acute esophageal variceal bleeding in cirrhotic patients: a meta-analysis of randomized controlled trials","volume":"31","author":"Halabi","year":"2016","journal-title":"J Gastroenterol Hepatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1055\/s-2007-966591","article-title":"A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding","volume":"39","author":"Lo","year":"2007","journal-title":"Endoscopy."},{"key":"B44","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1136\/gut.51.2.270","article-title":"The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations","volume":"51","author":"Tripathi","year":"2002","journal-title":"Gut."},{"key":"B45","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/MCG.0000000000001275","article-title":"Balloon-occluded retrograde transvenous obliteration (BRTO) versus transjugular intrahepatic portosystemic shunt (TIPS) for treatment of gastric varices because of portal hypertension: a systematic review and meta-analysis","volume":"54","author":"Paleti","year":"2020","journal-title":"J Clin Gastroenterol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.gie.2021.01.025","article-title":"Safety and efficacy of EUS-guided coil and glue injection for the primary prophylaxis of gastric variceal hemorrhage","volume":"94","author":"Kouanda","year":"2021","journal-title":"Gastrointest Endosc."},{"key":"B47","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1055\/a-1098-1817","article-title":"Efficacy and safety of endoscopic ultrasound-guided therapy versus direct endoscopic glue injection therapy for gastric varices: systematic review and meta-analysis","volume":"52","author":"Mohan","year":"2020","journal-title":"Endoscopy."},{"key":"B48","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/hep.32453","article-title":"Concurrent large spontaneous portosystemic shunt embolization for the prevention of overt hepatic encephalopathy after TIPS: a randomized controlled trial","volume":"76","author":"Lv","year":"2022","journal-title":"Hepatology."},{"key":"B49","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/hep.1840070124","article-title":"Compensated cirrhosis: natural history and prognostic factors","volume":"7","author":"Gin\u00e9s","year":"1987","journal-title":"Hepatology."},{"key":"B50","doi-asserted-by":"publisher","first-page":"42","DOI":"10.14218\/JCTH.2019.00048","article-title":"Pathophysiology and prevention of paracentesis-induced circulatory dysfunction: a concise review","volume":"8","author":"Kulkarni","year":"2020","journal-title":"J Clin Transl Hepatol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the american association for the study of liver diseases","volume":"74","author":"Biggins","year":"2021","journal-title":"Hepatology."},{"key":"B52","doi-asserted-by":"publisher","first-page":"251","DOI":"10.4254\/wjh.v5.i5.251","article-title":"Cirrhotic ascites review: pathophysiology, diagnosis and management","volume":"5","author":"Moore","year":"2013","journal-title":"World J Hepatol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s12072-008-9100-3","article-title":"Pathogenetic background for treatment of ascites and hepatorenal syndrome","volume":"2","author":"M\u00f8ller","year":"2008","journal-title":"Hepatol Int."},{"key":"B54","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/gut.2008.176495","article-title":"Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial","volume":"59","author":"Angeli","year":"2010","journal-title":"Gut."},{"key":"B55","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jceh.2020.12.002","article-title":"Midodrine improves the tolerability of diuretics in patients with acute-on-chronic liver failure-A pilot study","volume":"11","author":"Kulkarni","year":"2021","journal-title":"J Clin Exp Hepatol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jceh.2021.09.003","article-title":"Tuberculosis in cirrhosis - a diagnostic and management conundrum","volume":"12","author":"Mishra","year":"2022","journal-title":"J Clin Exp Hepatol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/ygh2.395","article-title":"Prevention of paracentesis-induced circulatory dysfunction\u2014a systematic review and network meta-analysis","volume":"2","author":"Kulkarni","year":"2020","journal-title":"GastroHep."},{"key":"B59","article-title":"Midodrine with albumin is safe and effective in preventing complications post-large volume paracentesis-an open labelled randomised controlled trial (NCT-03144713)","volume-title":"Hepatology.","author":"Kulkarni","year":"2018"},{"key":"B60","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jhep.2019.10.002","article-title":"Impact of cardiac function, refractory ascites and beta blockers on the outcome of patients with cirrhosis listed for liver transplantation","volume":"72","author":"Giannelli","year":"2020","journal-title":"J Hepatol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1111\/j.1572-0241.2008.01787.x","article-title":"Midodrine versus albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotics: a randomized pilot study","volume":"103","author":"Singh","year":"2008","journal-title":"Am J Gastroenterol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/hep.31513","article-title":"Letter to the editor: Midodrine for hepatic hydrothorax","volume":"73","author":"Kulkarni","year":"2021","journal-title":"Hepatology."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1097\/MEG.0000000000000743","article-title":"Rifaximin and midodrine improve clinical outcome in refractory ascites including renal function, weight loss, and short-term survival","volume":"28","author":"Hanafy","year":"2016","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1159\/000503559","article-title":"Tolvaptan response improves overall survival in patients with refractory ascites: a meta-analysis","volume":"38","author":"Bellos","year":"2020","journal-title":"Dig Dis."},{"key":"B65","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/apt.12025","article-title":"Meta-analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia","volume":"36","author":"Dahl","year":"2012","journal-title":"Aliment Pharmacol Ther."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1111\/liv.14703","article-title":"Terlipressin has stood the test of time: Clinical overview in 2020 and future perspectives","volume":"40","author":"Kulkarni","year":"2020","journal-title":"Liver Int."},{"key":"B67","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/liv.13968","article-title":"Long-term administration of human albumin improves survival in patients with cirrhosis and refractory ascites","volume":"39","author":"Di Pascoli","year":"2019","journal-title":"Liver Int."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.3748\/wjg.v20.i10.2704","article-title":"TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis","volume":"20","author":"Bai","year":"2014","journal-title":"World J Gastroenterol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jhep.2017.06.010","article-title":"Alfapump\u00ae system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study","volume":"67","author":"Bureau","year":"2017","journal-title":"J Hepatol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","article-title":"Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial","volume":"391","author":"Caraceni","year":"2018","journal-title":"Lancet."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.jhep.2018.08.006","article-title":"Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial","volume":"69","author":"Sol\u00e0","year":"2018","journal-title":"J Hepatol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/hep.31399","article-title":"Letter to the editor: sodium-glucose cotransporter-2 inhibitors are not the magic pills for control of ascites in cirrhosis and diabetes","volume":"73","author":"Kumar","year":"2021","journal-title":"Hepatology."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1002\/hep.31270","article-title":"Sodium-glucose cotransporter 2 inhibitors ameliorate ascites and peripheral edema in patients with cirrhosis and diabetes","volume":"72","author":"Montalvo-Gordon","year":"2020","journal-title":"Hepatology."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1111\/liv.14162","article-title":"Permanent indwelling peritoneal catheters for palliation of refractory ascites in end-stage liver disease: a systematic review","volume":"39","author":"Macken","year":"2019","journal-title":"Liver Int."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e116","DOI":"10.1136\/flgastro-2022-102128","article-title":"Palliative long-term abdominal drains for the management of refractory ascites due to cirrhosis: a consensus document","volume":"13","author":"Macken","year":"2022","journal-title":"Frontline Gastroenterol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.jhep.2019.07.002","article-title":"News in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the International Club of Ascites (ICA) consensus document","volume":"71","author":"Angeli","year":"2019","journal-title":"J Hepatol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/hep.27709","article-title":"Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial","volume":"62","author":"Cavallin","year":"2015","journal-title":"Hepatology."},{"key":"B78","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/hep.28396","article-title":"Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: a randomized controlled study","volume":"63","author":"Cavallin","year":"2016","journal-title":"Hepatology."},{"key":"B79","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1002\/lt.25454","article-title":"Impact of chronic kidney disease on outcomes in cirrhosis","volume":"25","author":"Wong","year":"2019","journal-title":"Liver Transpl."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/hep.30859","article-title":"Incidence, risk factors, and outcomes of transition of acute kidney injury to chronic kidney disease in cirrhosis: a prospective cohort study","volume":"71","author":"Maiwall","year":"2020","journal-title":"Hepatology."},{"key":"B81","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/tri.13388","article-title":"Simultaneous liver kidney transplantation","volume":"32","author":"Singal","year":"2019","journal-title":"Transpl Int."},{"key":"B82","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1007\/s10620-020-06136-2","article-title":"Inpatient mortality benefit with transjugular intrahepatic portosystemic shunt for hospitalized hepatorenal syndrome patients","volume":"65","author":"Charilaou","year":"2020","journal-title":"Dig Dis Sci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.dld.2021.09.008","article-title":"Transjugular intrahepatic porto-systemic shunt in cirrhotic patients with hepatorenal syndrome - chronic kidney disease: impact on renal function","volume":"54","author":"Ponzo","year":"2022","journal-title":"Dig Liver Dis."},{"key":"B84","doi-asserted-by":"publisher","first-page":"e00512","DOI":"10.14309\/ctg.0000000000000512","article-title":"Frailty as tested by the clinical frailty scale is a risk factor for hepatorenal syndrome in patients with liver cirrhosis","volume":"13","author":"Schleicher","year":"2022","journal-title":"Clin Transl Gastroenterol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"e1307","DOI":"10.1097\/01.HC9.0000897228.91307.0c","article-title":"Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies","volume":"7","author":"Curry","year":"2023","journal-title":"Hepatol Commun."},{"key":"B86","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology."},{"key":"B87","doi-asserted-by":"publisher","first-page":"5246","DOI":"10.3748\/wjg.v23.i28.5246","article-title":"Refractory hepatic encephalopathy in a patient with hypothyroidism: another element in ammonia metabolism","volume":"23","author":"D\u00edaz-Fontenla","year":"2017","journal-title":"World J Gastroenterol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"695","DOI":"10.2310\/JIM.0b013e318289e254","article-title":"Altered mental status in cirrhosis: etiologies and outcomes","volume":"61","author":"Rahimi","year":"2013","journal-title":"J Investig Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.mayocp.2015.03.003","article-title":"Refining the ammonia hypothesis: a physiology-driven approach to the treatment of hepatic encephalopathy","volume":"90","author":"Tapper","year":"2015","journal-title":"Mayo Clin Proc."},{"key":"B90","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S1665-2681(19)31392-4","article-title":"How to diagnose hepatic encephalopathy in the emergency department","volume":"12","author":"Gundling","year":"2013","journal-title":"Ann Hepatol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update","volume":"13","author":"Sarin","year":"2019","journal-title":"Hepatol Int."},{"key":"B92","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jceh.2018.06.007","article-title":"Hyperammonemia in hepatic encephalopathy","volume":"8","author":"Jayakumar","year":"2018","journal-title":"J Clin Exp Hepatol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1055\/s-0034-1382795","article-title":"Portosystemic shunt syndrome and endovascular management of hepatic encephalopathy","volume":"31","author":"Saad","year":"2014","journal-title":"Semin Intervent Radiol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1097\/MCG.0000000000001450","article-title":"Combined PEG3350 plus lactulose results in early resolution of hepatic encephalopathy and improved 28-day survival in acute-on-chronic liver failure","volume":"56","author":"Ahmed","year":"2022","journal-title":"J Clin Gastroenterol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1038\/ajg.2013.219","article-title":"A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy","volume":"108","author":"Sharma","year":"2013","journal-title":"Am J Gastroenterol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/hep.32255","article-title":"L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: a double-blind randomized controlled trial","volume":"75","author":"Jain","year":"2022","journal-title":"Hepatology."},{"key":"B97","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.clnu.2014.02.011","article-title":"Branched-chain amino acid supplementation in adults with cirrhosis and porto-systemic encephalopathy: systematic review","volume":"33","author":"Metcalfe","year":"2014","journal-title":"Clin Nutr."},{"key":"B98","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/apt.13435","article-title":"Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis","volume":"1","author":"Bajaj","year":"2016","journal-title":"Aliment Pharmacol Ther."},{"key":"B99","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/apt.12803","article-title":"Systematic review with meta-analysis: the effects of rifaximin in hepatic encephalopathy","volume":"40","author":"Kimer","year":"2014","journal-title":"Aliment Pharmacol Ther."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/0016-5085(91)90290-2","article-title":"Overt hepatic encephalopathy precipitated by zinc deficiency","volume":"100","author":"Van der Rijt","year":"1991","journal-title":"Gastroenterology."},{"key":"B101","doi-asserted-by":"publisher","first-page":"Cd008716","DOI":"10.1002\/14651858.CD008716.pub3","article-title":"Probiotics for people with hepatic encephalopathy","volume":"2","author":"Dalal","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"key":"B102","doi-asserted-by":"publisher","first-page":"989","DOI":"10.14309\/ajg.0000000000000603","article-title":"Important unresolved questions in the management of hepatic encephalopathy: an ISHEN consensus","volume":"115","author":"Bajaj","year":"2020","journal-title":"Am J Gastroenterol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/hep.29410","article-title":"L-ornithine L-aspartate in bouts of overt hepatic encephalopathy","volume":"67","author":"Sidhu","year":"2018","journal-title":"Hepatology."},{"key":"B104","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1007\/s00330-019-06644-4","article-title":"Intractable hepatic encephalopathy in cirrhotic patients: mid-term efficacy of balloon-occluded retrograde portosystemic shunt obliteration","volume":"30","author":"Mukund","year":"2020","journal-title":"Eur Radiol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1002\/hep.29306","article-title":"Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial","volume":"66","author":"Bajaj","year":"2017","journal-title":"Hepatology."},{"key":"B106","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jhep.2022.09.009","article-title":"A double-blind randomized placebo-controlled trial of albumin in outpatients with hepatic encephalopathy: HEAL study","volume":"78","author":"Fagan","year":"2023","journal-title":"J Hepatol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1007\/s12325-023-02430-3","article-title":"Human albumin infusion for the management of liver cirrhosis and its complications: an overview of major findings from meta-analyses","volume":"40","author":"Zheng","year":"2023","journal-title":"Adv Ther."},{"key":"B108","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.jhep.2017.11.008","article-title":"Potentially inappropriate liver transplantation in the era of the \u201csickest first\u201d policy - a search for the upper limits","volume":"68","author":"Linecker","year":"2018","journal-title":"J Hepatol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/liv.13589","article-title":"The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis","volume":"38","author":"M\u00f8ller","year":"2018","journal-title":"Liver Int."},{"key":"B110","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1055\/a-1869-7607","article-title":"Early diagnosis and prevention of infections in cirrhosis","volume":"42","author":"Kulkarni","year":"2022","journal-title":"Semin Liver Dis."},{"key":"B111","doi-asserted-by":"publisher","first-page":"101675","DOI":"10.1016\/j.clinre.2021.101675","article-title":"Efficacy and safety of obeticholic acid in liver disease-A systematic review and meta-analysis","volume":"45","author":"Kulkarni","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1002\/hep.26939","article-title":"Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats","volume":"59","author":"Verbeke","year":"2014","journal-title":"Hepatology."},{"key":"B113","doi-asserted-by":"publisher","first-page":"BSR20171015","DOI":"10.1042\/BSR20171015","article-title":"The beneficial effects of curcumin in cirrhotic rats with portal hypertension","volume":"37","author":"Hsu","year":"2017","journal-title":"Biosci Rep."},{"key":"B114","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jceh.2021.08.016","article-title":"Diagnosis and management of cirrhotic cardiomyopathy","volume":"12","author":"Kaur","year":"2022","journal-title":"J Clin Exp Hepatol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jacc.2009.12.075","article-title":"Cirrhotic cardiomyopathy","volume":"56","author":"Zardi","year":"2010","journal-title":"J Am Coll Cardiol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1161\/01.RES.0000189270.72915.D1","article-title":"Ca2+ influx-induced sarcoplasmic reticulum Ca2+ overload causes mitochondrial-dependent apoptosis in ventricular myocytes","volume":"97","author":"Chen","year":"2005","journal-title":"Circ Res."},{"key":"B117","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.jceh.2021.11.005","article-title":"A prospective study of prevalence and predictors of cirrhotic cardiomyopathy and its role in development of hepatorenal syndrome","volume":"12","author":"Anikhindi","year":"2022","journal-title":"J Clin Exp Hepatol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1093\/eurheartj\/eht246","article-title":"Interactions of the heart and the liver","volume":"34","author":"M\u00f8ller","year":"2013","journal-title":"Eur Heart J."},{"key":"B119","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/lt.24768","article-title":"Cirrhotic cardiomyopathy: implications for liver transplantation","volume":"23","author":"Liu","year":"2017","journal-title":"Liver Transpl."},{"key":"B120","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1161\/01.CIR.49.4.755","article-title":"Impaired left ventricular function in alcoholic cirrhosis with ascites. Ineffectiveness of ouabain","volume":"49","author":"Limas","year":"1974","journal-title":"Circulation."},{"key":"B121","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/hep.23852","article-title":"Beta-blockers in cirrhosis: friend and foe?","volume":"52","author":"Wong","year":"2010","journal-title":"Hepatology."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1111\/j.1572-0241.2005.41060.x","article-title":"Cardiac, neuroadrenergic, and portal hemodynamic effects of prolonged aldosterone blockade in postviral child A cirrhosis","volume":"100","author":"Pozzi","year":"2005","journal-title":"Am J Gastroenterol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1136\/gutjnl-2016-312670","article-title":"Acute-on-chronic liver failure: an update","volume":"66","author":"Hernaez","year":"2017","journal-title":"Gut."},{"key":"B124","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1056\/NEJMra1914900","article-title":"Acute-on-chronic liver failure","volume":"382","author":"Kumar","year":"2020","journal-title":"N Engl J Med."},{"key":"B125","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1002\/hep.30494","article-title":"Incidence and mortality of acute-on-chronic liver failure using two definitions in patients with compensated cirrhosis","volume":"69","author":"Mahmud","year":"2019","journal-title":"Hepatology."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/hep.28740","article-title":"Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure","volume":"64","author":"Cl\u00e0ria","year":"2016","journal-title":"Hepatology."},{"key":"B127","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nm.3516","article-title":"Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2","volume":"20","author":"O'Brien","year":"2014","journal-title":"Nat Med."},{"key":"B128","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.jhep.2019.11.009","article-title":"Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF","volume":"72","author":"Moreau","year":"2020","journal-title":"J Hepatol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"501","DOI":"10.7861\/clinmed.2020-0631","article-title":"Acute-on-chronic liver failure","volume":"20","author":"Kumar","year":"2020","journal-title":"Clin Med."},{"key":"B130","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1097\/MCG.0000000000000538","article-title":"Population-representative incidence of acute-on-chronic liver failure: a prospective cross-sectional study","volume":"50","author":"Qin","year":"2016","journal-title":"J Clin Gastroenterol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/hep.27795","article-title":"Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults","volume":"62","author":"Shi","year":"2015","journal-title":"Hepatology."},{"key":"B132","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/hep.30205","article-title":"Flare of autoimmune hepatitis causing acute on chronic liver failure: diagnosis and response to corticosteroid therapy","volume":"70","author":"Anand","year":"2019","journal-title":"Hepatology."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1007\/s12072-022-10372-1","article-title":"Acute variceal bleeding portends poor outcomes in patients with acute-on-chronic liver failure: a propensity score matched study from the APASL ACLF Research Consortium (AARC)","volume":"16","author":"Sharma","year":"2022","journal-title":"Hepatol Int."},{"key":"B134","doi-asserted-by":"publisher","first-page":"225","DOI":"10.14309\/ajg.0000000000001595","article-title":"Acute-on-chronic liver failure clinical guidelines","volume":"117","author":"Bajaj","year":"2022","journal-title":"Am J Gastroenterol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"607","DOI":"10.14309\/ajg.0000000000001611","article-title":"Primary norfloxacin prophylaxis for apasl-defined acute-on-chronic liver failure: a placebo-controlled double-blind randomized trial","volume":"117","author":"Kulkarni","year":"2022","journal-title":"Am J Gastroenterol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1111\/jgh.15400","article-title":"Omega-3 fatty acid lipid emulsions are safe and effective in reducing endotoxemia and sepsis in acute-on-chronic liver failure: An open-label randomized controlled trial","volume":"36","author":"Kulkarni","year":"2021","journal-title":"J Gastroenterol Hepatol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/hep.27077","article-title":"Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures","volume":"60","author":"Bajaj","year":"2014","journal-title":"Hepatology."},{"key":"B138","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1002\/hep.25947","article-title":"Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience","volume":"56","author":"Bajaj","year":"2012","journal-title":"Hepatology."},{"key":"B139","doi-asserted-by":"publisher","first-page":"816","DOI":"10.14309\/ajg.0000000000001760","article-title":"Response to Mir et al","volume":"117","author":"Kulkarni","year":"2022","journal-title":"Am J Gastroenterol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/hep.30412","article-title":"Management of sepsis in patients with cirrhosis: current evidence and practical approach","volume":"70","author":"Simonetto","year":"2019","journal-title":"Hepatology."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1136\/gutjnl-2017-314324","article-title":"Assessment of sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections","volume":"67","author":"Piano","year":"2018","journal-title":"Gut."},{"key":"B142","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/liv.13980","article-title":"Applicability of sepsis-3 criteria and quick sequential organ failure assessment in patients with cirrhosis hospitalised for bacterial infections","volume":"39","author":"Augustinho","year":"2019","journal-title":"Liver Int."},{"key":"B143","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/hep.27849","article-title":"Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis","volume":"62","author":"Gustot","year":"2015","journal-title":"Hepatology."},{"key":"B144","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1007\/s12072-021-10206-6","article-title":"\u2018First week' is the crucial period for deciding living donor liver transplantation in patients with acute-on-chronic liver failure","volume":"15","author":"Choudhury","year":"2021","journal-title":"Hepatol Int"},{"key":"B145","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1002\/hep.31657","article-title":"Letter to the editor: Living donor liver transplantation or deceased donor liver transplantation in high model for end-stage liver disease score-which is better?","volume":"73","author":"Kulkarni","year":"2021","journal-title":"Hepatology."},{"key":"B146","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3389\/fimmu.2019.00973","article-title":"Dysfunctional immune response in acute-on-chronic liver failure: it takes two to tango","volume":"10","author":"Martin-Mateos","year":"2019","journal-title":"Front Immunol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.4110\/in.2018.18.e27","article-title":"Damage-associated molecular patterns in inflammatory diseases","volume":"18","author":"Roh","year":"2018","journal-title":"Immune Netw."},{"key":"B148","doi-asserted-by":"publisher","first-page":"R227","DOI":"10.1186\/cc11882","article-title":"Role of predisposition, injury, response and organ failure in the prognosis of patients with acute-on-chronic liver failure: a prospective cohort study","volume":"16","author":"Jalan","year":"2012","journal-title":"Crit Care."},{"key":"B149","doi-asserted-by":"publisher","first-page":"e53885","DOI":"10.1371\/journal.pone.0053885","article-title":"The predisposition, infection, response and organ failure (Piro) sepsis classification system: results of hospital mortality using a novel concept and methodological approach","volume":"8","author":"Granja","year":"2013","journal-title":"PLoS ONE."},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1007\/s001340051129","article-title":"Immunomodulatory therapies in sepsis","author":"Kox","year":"2000","journal-title":"Intensive Care Med."},{"key":"B151","doi-asserted-by":"publisher","first-page":"e023754","DOI":"10.1136\/bmjopen-2018-023754","article-title":"ATTIRE: albumin to prevent infection in chronic liver failure: study protocol for an interventional randomised controlled trial","volume":"8","author":"China","year":"2018","journal-title":"BMJ Open."},{"key":"B152","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1038\/s41598-022-09505-1","article-title":"Safety and efficacy of terlipressin in acute-on-chronic liver failure with hepatorenal syndrome-acute kidney injury (HRS-AKI): a prospective cohort study","volume":"12","author":"Kulkarni","year":"2022","journal-title":"Sci Rep."},{"key":"B153","doi-asserted-by":"publisher","first-page":"e233089","DOI":"10.1136\/bcr-2019-233089","article-title":"Terlipressin-induced ischaemic skin necrosis","volume":"13","author":"Kulkarni","year":"2020","journal-title":"BMJ Case Rep."},{"key":"B154","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1111\/apt.17195","article-title":"Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure","volume":"56","author":"Wong","year":"2022","journal-title":"Aliment Pharmacol Ther."},{"key":"B155","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/liv.14806","article-title":"Therapeutic plasma-exchange improves systemic inflammation and survival in acute-on-chronic liver failure: a propensity-score matched study from AARC","volume":"41","author":"Maiwall","year":"2021","journal-title":"Liver Int."},{"key":"B156","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s12072-022-10312-z","article-title":"Fecal microbiota transplantation in alcohol-associated acute-on-chronic liver failure: an open-label clinical trial","volume":"16","author":"Sharma","year":"2022","journal-title":"Hepatol Int."},{"key":"B157","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jceh.2017.08.001","article-title":"Liver transplantation for acute on chronic liver failure","volume":"7","author":"Choudhary","year":"2017","journal-title":"J Clin Exp Hepatol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/apt.15793","article-title":"Systematic review with meta-analysis: liver transplant provides survival benefit in patients with acute on chronic liver failure","volume":"52","author":"Abdallah","year":"2020","journal-title":"Aliment Pharmacol Ther."},{"key":"B159","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.jhep.2017.06.009","article-title":"Liver transplantation in the most severely ill cirrhotic patients: a multicenter study in acute-on-chronic liver failure grade 3","volume":"67","author":"Artru","year":"2017","journal-title":"J Hepatol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/lt.26499","article-title":"Location and allocation: inequity of access to liver transplantation for patients with severe acute-on-chronic liver failure in Europe","volume":"28","author":"Artzner","year":"2022","journal-title":"Liver Transpl."},{"key":"B161","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1097\/SLA.0000000000000265","article-title":"Liver transplantation in highest acuity recipients: identifying factors to avoid futility","volume":"259","author":"Petrowsky","year":"2014","journal-title":"Ann Surg."},{"key":"B162","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1111\/liv.15328","article-title":"Epidemiology of liver failure in Asia-Pacific region","volume":"42","author":"Jindal","year":"2022","journal-title":"Liver Int."},{"key":"B163","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jhep.2022.10.008","article-title":"Prognostic and therapeutic significance of microbial cell-free DNA in plasma of people with acute decompensation of cirrhosis","volume":"78","author":"Li","year":"2023","journal-title":"J Hepatol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"929","DOI":"10.14309\/ajg.0000000000000201","article-title":"Drug-induced acute-on-chronic liver failure in asian patients","volume":"114","author":"Devarbhavi","year":"2019","journal-title":"Am J Gastroenterol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jceh.2020.12.007","article-title":"Severe acute respiratory syndrome coronavirus 2-related acute-on-chronic liver failure","volume":"11","author":"Kumar","year":"2021","journal-title":"J Clin Exp Hepatol."},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-328451.","article-title":"SARS-CoV-2 Omicron variant infection was associated with higher morbidity in patients with cirrhosis","author":"Kulkarni","year":"2022","journal-title":"Gut."},{"key":"B167","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/hep4.1853","article-title":"SARS-CoV-2 infections among patients with liver disease and liver transplantation who received COVID-19 vaccination","volume":"6","author":"Moon","year":"2021","journal-title":"Hepatol Commun."},{"key":"B168","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jceh.2021.09.007","article-title":"COVID-19 masquerading as autoimmune hepatitis (AIH) flare-the first report","volume":"12","author":"Kulkarni","year":"2022","journal-title":"J Clin Exp Hepatol."},{"key":"B169","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.jceh.2022.06.004","article-title":"Post-COVID-19 cholestasis: a case series and review of literature","volume":"12","author":"Kulkarni","year":"2022","journal-title":"J Clin Exp Hepatol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/lt.25675","article-title":"The development and outcome of acute-on-chronic liver failure after surgical interventions","volume":"26","author":"Klein","year":"2020","journal-title":"Liver Transpl."},{"key":"B171","doi-asserted-by":"publisher","first-page":"e00025","DOI":"10.14309\/ctg.0000000000000025","article-title":"Sarcopenia is associated with development of acute-on-chronic liver failure in decompensated liver cirrhosis receiving transjugular intrahepatic portosystemic shunt","volume":"10","author":"Praktiknjo","year":"2019","journal-title":"Clin Transl Gastroenterol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1002\/hep4.1712","article-title":"Elective surgery but not transjugular intrahepatic portosystemic shunt precipitates acute-on-chronic liver failure","volume":"5","author":"Chang","year":"2021","journal-title":"Hepatol Commun."},{"key":"B173","doi-asserted-by":"publisher","first-page":"12593","DOI":"10.1038\/s41598-021-92087-1","article-title":"Use of skeletal muscle index as a predictor of short-term mortality in patients with acute-on-chronic liver failure","volume":"11","author":"Li","year":"2021","journal-title":"Sci Rep."},{"key":"B174","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.jhep.2021.09.004","article-title":"Sarcopenia should be evaluated in patients with acute-on-chronic liver failure and candidates for liver transplantation","volume":"76","author":"Artru","year":"2022","journal-title":"J Hepatol."},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000001745.","article-title":"Assessment of sarcopenia using muscle ultrasound in patients with cirrhosis and sarcopenic obesity (AMUSE STUDY)","author":"Dhariwal","year":"2022","journal-title":"J Clin Gastroenterol."},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2023.01.009","article-title":"Midodrine vs. Albumin to prevent paracentesis induced circulatory dysfunction in acute on chronic liver failure patients in the outpatient clinic\u2014a randomized controlled trial","author":"Sujith Reddy","year":"2023","journal-title":"J Clin Exp Hepatol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jceh.2021.07.010","article-title":"Low volume plasma exchange and low dose steroid improve survival in patients with alcohol-related acute on chronic liver failure and severe alcoholic hepatitis - preliminary experience","volume":"12","author":"Kumar","year":"2022","journal-title":"J Clin Exp Hepatol."},{"key":"B178","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/liv.15361","article-title":"APASL-ACLF research consortium-artificial intelligence (AARC-AI) model precisely predicts outcomes in acute-on-chronic liver failure patients","volume":"43","author":"Verma","year":"2023","journal-title":"Liver Int."},{"key":"B179","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1111\/ajt.15852","article-title":"Liver transplantation for critically ill cirrhotic patients: stratifying utility based on pretransplant factors","volume":"20","author":"Artzner","year":"2020","journal-title":"Am J Transplant."},{"key":"B180","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/lt.26280","article-title":"Pretransplant intensive care unit management and selection of grade 3 acute-on-chronic liver failure transplant candidates","volume":"28","author":"Michard","year":"2022","journal-title":"Liver Transpl."},{"key":"B181","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1016\/j.jhep.2022.10.029","article-title":"Attitudes toward liver transplantation for ACLF-3 determine equity of access","volume":"78","author":"Artzner","year":"2023","journal-title":"J Hepatol."},{"key":"B182","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/lt.26215","article-title":"Extensive health care utilization and costs of an early liver transplantation program for alcoholic hepatitis","volume":"28","author":"Im","year":"2022","journal-title":"Liver Transpl."},{"key":"B183","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.jhep.2021.12.034","article-title":"Statin exposure is associated with reduced development of acute-on-chronic liver failure in a Veterans Affairs cohort","volume":"76","author":"Mahmud","year":"2022","journal-title":"J Hepatol."},{"key":"B184","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.cgh.2021.07.012","article-title":"Decreasing von Willebrand factor levels upon nonselective beta blocker therapy indicate a decreased risk of further decompensation, acute-on-chronic liver failure, and death","volume":"20","author":"Jachs","year":"2022","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B185","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/liv.15207","article-title":"Effect of rifaximin on infections, acute-on-chronic liver failure and mortality in alcoholic hepatitis: a pilot study (RIFA-AH)","volume":"42","author":"Jim\u00e9nez","year":"2022","journal-title":"Liver Int."},{"key":"B186","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41598-019-57284-z","article-title":"Recombinant alkaline phosphatase prevents acute on chronic liver failure","volume":"10","author":"Engelmann","year":"2020","journal-title":"Sci Rep."},{"key":"B187","doi-asserted-by":"publisher","first-page":"e89374","DOI":"10.1371\/journal.pone.0089374","article-title":"Catalytic signature of a heat-stable, chimeric human alkaline phosphatase with therapeutic potential","volume":"9","author":"Kiffer-Moreira","year":"2014","journal-title":"PLoS ONE."},{"key":"B188","first-page":"347","article-title":"A double blind, randomised, placebo-controlled study to assess safety and tolerability of oral enterosorbent Yaq-001 in cirrhotic patients (CARBALIVE Consortium)","author":"Macnaughtan","year":"2021","journal-title":"J Hepatol."},{"key":"B189","author":"Agarwal","year":"2021","journal-title":"P076 a Multi-Centre, Randomized Controlled Study, to Evaluate the Safety and Performance of the DIALIVE Liver Dialysis Device in Patients With Acute on Chronic Liver Failure (ACLF) Versus Standard of Care (SOC)(ALIVER Consortium)"},{"key":"B190","author":"Ca\u00f1izares","year":"2021","journal-title":"P077 Pathophysiological Basis of Resolution of Acute-on-Chronic Liver Failure (ACLF) Induced by the Novel Liver Dialysis Device, DIALIVE (ALIVER Consortium)"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1060073\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T05:49:10Z","timestamp":1686808150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1060073\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,15]]},"references-count":190,"alternative-id":["10.3389\/fmed.2023.1060073"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1060073","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,15]]},"article-number":"1060073"}}